Stock Research for SAN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SAN Stock Chart & Research Data

The SAN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SAN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SAN Due diligence Resources & Stock Charts

The SAN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SAN Detailed Price Forecast - CNN Money CNN View SAN Detailed Summary - Google Finance
Yahoo View SAN Detailed Summary - Yahoo! Finance Zacks View SAN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SAN Trends & Analysis - Trade-Ideas Barrons View SAN Major Holders - Barrons
NASDAQ View SAN Call Transcripts - NASDAQ Seeking View SAN Breaking News & Analysis - Seeking Alpha
Spotlight View SAN Annual Report - CompanySpotlight.com OTC Report View SAN OTC Short Report - OTCShortReport.com
TradeKing View SAN Fundamentals - TradeKing Charts View SAN SEC Filings - Bar Chart
WSJ View Historical Prices for SAN - The WSJ Morningstar View Performance/Total Return for SAN - Morningstar
MarketWatch View the Analyst Estimates for SAN - MarketWatch CNBC View the Earnings History for SAN - CNBC
StockMarketWatch View the SAN Earnings - StockMarketWatch MacroAxis View SAN Buy or Sell Recommendations - MacroAxis
Bullish View the SAN Bullish Patterns - American Bulls Short Pains View SAN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SAN Stock Mentions - StockTwits PennyStocks View SAN Stock Mentions - PennyStockTweets
Twitter View SAN Stock Mentions - Twitter Invest Hub View SAN Investment Forum News - Investor Hub
Yahoo View SAN Stock Mentions - Yahoo! Message Board Seeking Alpha View SAN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SAN - SECform4.com Insider Cow View Insider Transactions for SAN - Insider Cow
CNBC View SAN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SAN - OTC Markets
Yahoo View Insider Transactions for SAN - Yahoo! Finance NASDAQ View Institutional Holdings for SAN - NASDAQ


Stock Charts

FinViz View SAN Stock Insight & Charts - FinViz.com StockCharts View SAN Investment Charts - StockCharts.com
BarChart View SAN Stock Overview & Charts - BarChart Trading View View SAN User Generated Charts - Trading View




Latest Financial News for SAN


Sanofi: FDA approves asthma indication for Dupixent® (dupilumab)
Posted on Friday October 19, 2018

FDA approves asthma indication for Dupixent® (dupilumab) Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic.


European politicians call for clampdown on tax trade trick
Posted on Friday October 19, 2018

European politicians have called for action to tackle dividend stripping after Reuters and other media revealed how large banks were involved in trading schemes that cost taxpayers billions of euros. In Germany's biggest post-war fraud investigation, prosecutors in Cologne are investigating banks involved in the trades, which secured illicit double tax rebates on dividend payouts. Reuters spoke to bankers, officials and people directly involved in the probe and reviewed thousands of pages of internal bank files, correspondence and legal papers obtained as part of a European media investigation called the "cum-ex files" coordinated by non-profit newsroom Correctiv.


Sanofi receives positive CHMP opinion for dengue vaccine
Posted on Friday October 19, 2018

Dengue fever is a debilitating disease typically leading to prolonged fever and severe joint pain. Dengue infection can progress unpredictably to a life-threatening form of the disease called dengue haemorrhagic fever that often requires hospitalized care. Today, there is no specific treatment available for dengue disease.


Santander Consumer Bank AS -- Moody's affirms Santander Consumer Bank AS's ratings and assigns a Ba2(hyb) rating to the additional Tier 1 non-viability securities
Posted on Thursday October 18, 2018

Moody's Investors Service has today affirmed Santander Consumer Bank AS's (SCB) Baseline Credit Assessment (BCA) of baa3, adjusted BCA of baa2, long-term and short-term local and foreign currency deposit, issuer and senior unsecured ratings of A3, Prime-2, Counterparty Risk (CR) assessments of A2(cr)/Prime-1(cr) and Counterparty Risk Rating of A2/Prime-1. At the same time, Moody's assigned a Ba2(hyb) rating to SCB's low trigger Additional Tier 1 (AT1) securities.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.